Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy ; volume:7 ; number:1 ; day:25 ; month:7 ; year:2019 ; pages:1-11 ; date:12.2019
Acta Neuropathologica Communications ; 7, Heft 1 (25.7.2019), 1-11, 12.2019
- Urheber
-
Kanemaru, Yu
Natsumeda, Manabu
Okada, Masayasu
Saito, Rie
Kobayashi, Daiki
Eda, Takeyoshi
Watanabe, Jun
Saito, Shoji
Tsukamoto, Yoshihiro
Oishi, Makoto
Saito, Hirotake
Nagahashi, Masayuki
Sasaki, Takahiro
Hashizume, Rintaro
Aoyama, Hidefumi
Wakai, Toshifumi
Kakita, Akiyoshi
Fujii, Yukihiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-019-0774-7
- URN
-
urn:nbn:de:101:1-2019121804290680530565
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kanemaru, Yu
- Natsumeda, Manabu
- Okada, Masayasu
- Saito, Rie
- Kobayashi, Daiki
- Eda, Takeyoshi
- Watanabe, Jun
- Saito, Shoji
- Tsukamoto, Yoshihiro
- Oishi, Makoto
- Saito, Hirotake
- Nagahashi, Masayuki
- Sasaki, Takahiro
- Hashizume, Rintaro
- Aoyama, Hidefumi
- Wakai, Toshifumi
- Kakita, Akiyoshi
- Fujii, Yukihiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer